|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0072348,
umls-concept:C0155626,
umls-concept:C0522523,
umls-concept:C0872913,
umls-concept:C1418370,
umls-concept:C1514496,
umls-concept:C1522318,
umls-concept:C1705930,
umls-concept:C1948041,
umls-concept:C2347515
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-8-19
|
|
pubmed:abstractText |
To examine the safety and efficacy of low-dose tenecteplase, administered before facilitated percutaneous coronary intervention (PCI) to restore Thrombolysis In Myocardial Infarction (TIMI) grade 2 or 3 blood flow in the infarct related artery (IRA) in patients with ST elevation myocardial infarction (STEMI) scheduled to undergo PCI with a shortest anticipated delay of 30 min.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1522-726X
|
|
pubmed:author |
pubmed-author:Anastasiou-NanaMariaM,
pubmed-author:CharbisPanagiotisP,
pubmed-author:DrakosStavros GSG,
pubmed-author:KanakakisJohnJ,
pubmed-author:MaroulidisGeorge DGD,
pubmed-author:NanasJohn NJN,
pubmed-author:NtalianisArgirios SAS,
pubmed-author:RokasStylianosS,
pubmed-author:SkoumbourdisEmmanuelE,
pubmed-author:TsagalouEleftheria PEP,
pubmed-author:TzoumelePanagiotisP
|
|
pubmed:copyrightInfo |
2009 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
74
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
398-405
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19360864-Aged,
pubmed-meshheading:19360864-Angioplasty, Balloon, Coronary,
pubmed-meshheading:19360864-Anticoagulants,
pubmed-meshheading:19360864-Aspirin,
pubmed-meshheading:19360864-Combined Modality Therapy,
pubmed-meshheading:19360864-Coronary Angiography,
pubmed-meshheading:19360864-Coronary Circulation,
pubmed-meshheading:19360864-Drug Administration Schedule,
pubmed-meshheading:19360864-Female,
pubmed-meshheading:19360864-Fibrinolytic Agents,
pubmed-meshheading:19360864-Greece,
pubmed-meshheading:19360864-Heparin,
pubmed-meshheading:19360864-Hospitalization,
pubmed-meshheading:19360864-Humans,
pubmed-meshheading:19360864-Male,
pubmed-meshheading:19360864-Middle Aged,
pubmed-meshheading:19360864-Myocardial Infarction,
pubmed-meshheading:19360864-Patient Transfer,
pubmed-meshheading:19360864-Platelet Aggregation Inhibitors,
pubmed-meshheading:19360864-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:19360864-Thrombolytic Therapy,
pubmed-meshheading:19360864-Time Factors,
pubmed-meshheading:19360864-Tissue Plasminogen Activator,
pubmed-meshheading:19360864-Treatment Outcome,
pubmed-meshheading:19360864-Vascular Patency
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial.
|
|
pubmed:affiliation |
Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
